Strategies of antibiotic treatment of urinary tract infections in children
N. D. Bunyatyan,
V. I. Petrov,
O. V. Shatalova,
A. V. Ponomareva,
G. I. Gorodetskaya,
А. В. Prokofiev https://doi.org/10.37489/0235-2990-2021-66-11-12-44-51
Abstract
The review presents the main directions of antibiotic therapy associated with rational pharmacotherapy of urinary tract infections (UTIs) in pediatric practice. As a serious pediatric problem, UTIs are often prone to recurrence, as well as may lead to the formation of more severe forms of urinary system diseases. Antibiotic therapy, timely and adequate in terms of etiological factors, drug and dosage choice, route of administration, as well as patient’s age, allows to avoid further progression of the disease, as well as development of disability in patients.
About the Authors
N. D. Bunyatyan
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Natalya D. Bunyatyan — D. Sc. in pharmaceutical sciences,
Professor
ResearcherID: D-3071-2018.
eLIBRARY SPIN: 9853-1232. Scopus Author ID: 6506018057
8/2 Petrovsky blvd., Moscow, 127051
V. I. Petrov
Volgograd State Medical University of the Ministry of Health of the Russian Federation; Scientific Center for Innovative Medicines with Pilot Production
Russian Federation
Russian Federation
Vladimir I. Petrov — D. Sc. in medicine, Professor
Volgograd
ResearcherID: D-9412-2016.
eLIBRARY SPIN: 148296. Scopus Author ID: 7402843021
O. V. Shatalova
I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation;
Russian Federation
Russian Federation
Olga V. Shatalova — D. Sc. in medicine
Volgograd
eLIBRARY SPIN: 478471. Scopus Author ID: 57188798913
A. V. Ponomareva
I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation; Volgograd Scientific Medical Center
Russian Federation
Russian Federation
Angelika V. Ponomareva — D. Sc. in medicine
Volgograd
ResearcherID: H-4714-2013. eLIBRARY SPIN code:614388
G. I. Gorodetskaya
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation; Volgograd State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Galina I. Gorodetskaya — Senior Analyst of the Center for
Clinical Pharmacology
Moscow
ResearcherID: D-3596-2018. eLIBRARY
SPIN: 8346-3293. Scopus Author ID: 57196437441
А. В. Prokofiev
Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation; Volgograd State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Alexey B. Prokofiev — D. Sc. in medicine, Professor
Moscow
ResearcherID: D-2961-2018. eLIBRARY SPIN: 1003-0672.
Scopus Author ID: 57189082881
References
1. Shaikh N., Morone N.E., Bost J.E., Farrell M.H. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008; 27 (4): 302–308. doi: 10.1097/INF.0b013e31815e4122.
2. O'Brien K., Stanton N., Edwards A., Hood K., Butler C.C. Prevalence of urinary tract infection (UTI) in sequential acutely unwell children presenting in primary care: exploratory study. Scand J Prim Health Care. 2011; 29 (1): 19–22. doi: 10.3109/02813432.2011.554268.
3. Chang S.L., Shortliffe L.D. Pediatric urinary tract infections. Pediatr Clin North Am. 2006; 53: 379–400. doi:10.1016/j.pcl.2006.02.011.
4. Leroy S., Gervaix A. Procalcitonin, a useful biomarker in pediatric urinary tract infection. Arch Pediatr. 2013; 20 (1): 54–62. doi:10.1016/j.arcped.2012.10.025.
5. Federal'nye klinicheskie rekomendacii «Infekciya mochevyvodyashchih putej u detej». Moscow: Soyuz pediatrov Rossii, 2018. (in Russian)]
6. Shaikh N., Craig J.C., Rovers M.M. et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr. 2014; 168 (10): 893–900. doi: 10.1001/jamapediatrics.2014.637.
7. Dahlén G., Blomqvist S., Almståhl A., Carlén A. Virulence factors and antibiotic susceptibility in enterococci isolated from oral mucosal and deep infections. J Oral Microbiol. 2012; 4. doi:10.3402/jom.v4i0.10855.
8. Chang S.L., Shortliffe L.D. Pediatric urinary tract infections. Pediatr Clin North Am. 2006; 53 (3): 379. doi: 10.1016/j.pcl.2006.02.011.
9. Montini G., Tullus K., Hewitt I. Febrile urinary tract infections in children. N Engl J Med. 2011; 365 (3): 239–250. doi:10.1056/NEJMra1007755.
10. Shaikh N., Hoberman A. Urinary tract infections in children: epidemiology and risk factors. In: Edwards M.S., Mattoo T.K. eds. UpToDate. 2019.
11. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011; 128 (3): 595–610. doi:10.1542/peds.2011-1330.
12. Miller W.R., Munita J.M., Arias C.A. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014; 12 (10): 1221–1236. doi: 10.1586/14787210.2014.956092.
13. Nallapareddy S.R., Sillanpää J., Mitchell J. et al. Conservation of Ebptype pilus genes among Enterococci and demonstration of their role in adherence of Enterococcus faecalis to human platelets. Infect Immun. 2011; 79 (7): 2911–2920. doi:10.1128/IAI.00039-11.
14. Kaufman D., Fairchild K.D. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev. 2004; 17 (3): 638–680. doi: 10.1128/CMR.17.3.638-680.2004.
15. European Association of Urology (EAU)-European Society for Paediatric Urology (ESPU): Guidelines on paediatric urology (2019).
16. Public Health England (PHE): Diagnosis of urinary tract infections – Quick reference tool for primary care for consultation and local adaptation (2019).
17. National Institute for Health and Care Excellence (NICE): Clinical guideline on urinary tract infection in under 16s — Diagnosis and management (2018).
18. Infectious Diseases Society of America (IDSA): Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. 8.
19. Mathew J. L. Can we predict antibiotic-resistance in urinary tract infection/ J. L. Mathew, R. Sinha. Indian Pediatrics. 2016; 53 (6): 519–521.
20. Gabrielyan N. I., Gorskaya E. M., Cirul'nikova O. M. Faktory riska i nozokomial'nye infekcii, vyzyvaemye enterokokkami. Vestnik transplantologii i iskusstvennyh organov. 2015; 17 (2): 64–69. (in Russian)]
21. Yakubov R., van den Akker M., Machamad K., Hochberg A., Nadir E., Klein A. Antimicrobial resistance among uropathogens that cause childhood community-acquired urinary tract infections in central Israel. Pediatr Infect Dis J. 2017; 36 (1): 113–115. doi: 10.1097/INF.0000000000001373.
22. Bryce A., Hay A.D., Lane I.F., Thornton H.V., Wootton M., Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ. 2016; 352: i939. Published 2016 Mar 15. doi: 10.1136/bmj.i939.
23. Bryce A., Costelloe C., Wootton M., Butler C.C., Hay A.D. Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study. J Antimicrob Chemother. 2018; 73 (5): 1359–1367. doi: 10.1093/jac/dkx525.
24. Degnan L.A., Milstone A.M., Diener-West M., Lee C.K. Extended-Spectrum Beta-Lactamase Bacteria From Urine Isolates in Children. J Pediatr Pharmacol Ther. 2015; 20 (5): 373–377. doi: 10.5863/1551-6776-20.5.373.
25. The SCOUT study: Short course therapy for urinary tract infections in children (SCOUT). https://clinicaltrials.gov/ct2/show/NCT01595529 (2019).
26. Hoberman A., Wald E.R., Hickey R.W. et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999; 104 (1): 79.
27. Degnan L.A., Milstone A.M., Diener-West M., Lee C.K. Extended-Spectrum Beta-Lactamase Bacteria From Urine Isolates in Children. J Pediatr Pharmacol Ther. 2015; 20 (5): 373–377. doi: 10.5863/1551-6776-20.5.373.
28. Montini G., Toffolo A., Zucchetta P. et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007; 335 (7616): 386. doi: 10.1136/bmj.39244.692442.55.
Review
For citations:
Bunyatyan N.D., Petrov V.I., Shatalova O.V., Ponomareva A.V., Gorodetskaya G.I., Prokofiev А.В. Strategies of antibiotic treatment of urinary tract infections in children. Antibiot Khimioter = Antibiotics and Chemotherapy. 2021;66(11-12):44-51. (In Russ.) https://doi.org/10.37489/0235-2990-2021-66-11-12-44-51
Views:
443
Email this article 